Cancer News and Research

Latest Cancer News and Research

Minority patients more likely to have surgeries at centres handling low numbers of similar procedures

Minority patients in New York City appear less likely than white patients to have surgeries performed by surgeons or at facilities that have handled large numbers of similar procedures in the past, according to a report in the February issue of Archives of Surgery, one of the JAMA/Archives journals.

16 Feb 2010

Over 96% of SIDS cases due to known risk factors

Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.

16 Feb 2010

US Oncology honored as inaugural inductee to Texas Governor's Business Hall of Fame

US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.

16 Feb 2010

CNRS-Institut researchers identify 'virulence factor' that inhibits host immune response

Oncogenic retroviruses are a particular family of viruses that can cause some types of cancer. Thierry Heidmann and his colleagues in the CNRS-Institut Gustave Roussy-Université Paris Sud 11 "Rétrovirus endogènes et éléments rétroïdes des eucaryotes supérieurs" Laboratory have studied these viruses. They have identified a "virulence factor" that inhibits the host immune response and allows the virus to spread throughout the body.

16 Feb 2010

NorTech announces winners of annual Innovation Awards program

NorTech, in partnership with Crain's Cleveland Business, is pleased to announce the winners of its annual Innovation Awards program which honors the achievements of Northeast Ohio's most innovative organizations and leaders.

16 Feb 2010

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

The new decade may herald an era of cell therapy -- treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.

16 Feb 2010

Public health researchers at UNC to lead multi-state initiative to prevent cervical cancer

Asserting that no one should die from cervical cancer, public health researchers at the University of North Carolina at Chapel Hill are leading a multi-state initiative to prevent - or even eradicate - the disease.

16 Feb 2010

Annual Income Tax Check-Off for Breast and Cervical Research campaign launched

The Pennsylvania Breast Cancer Coalition has launched its annual Income Tax Check-Off for Breast and Cervical Research campaign to fund PA researchers. By simply checking YES on line 35 of the PA 40 tax form, any taxpayer can donate all or part of their state income tax refund to breast and cervical cancer research.

16 Feb 2010

Researchers identify potential therapeutic targets for treatment of neuroblastoma

A team of researchers, led by Patrick Mehlen, at Universit- de Lyon, France, has identified the protein NT-3 and the cell-surface molecule to which it binds (TrkC) as potential therapeutic targets for the treatment of neuroblastoma - the most frequent solid tumor in young children- by studying human neuroblastoma cells in vitro and after xenotransplantation into mice and chicks.

15 Feb 2010

ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center

ERYtech Pharma, a specialty pharma company located in France and in USA (Philadelphia), is pleased to announce a collaborative research agreement in the field of personalized medicine focusing on ERYtech’s flagship product, GRASPA®, which consists of red blood cell-encapsulated L-asparaginase (L-ASP).

15 Feb 2010

LCA announces new internet link with renowned lung cancer research center in Zhuhai, China

Lung Cancer Alliance (LCA) announced today a new internet link with a renown lung cancer research center at the 5th Affiliated Hospital of Sun Yat-Sen University, in Zhuhai, China.

15 Feb 2010

New conference to discuss issues surrounding breast cancer to take place at UWE

An opportunity to join a forum to discuss issues surrounding breast cancer is taking place at the University of the West of England on Saturday 3 July 2010.

15 Feb 2010

Stem cells intentionally cut and then repair their own DNA to develop new tissues

A new study from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa suggests that stem cells intentionally break their own DNA as a way of regulating tissue development. The study, published in Proceedings of the National Academy of Science (PNAS), could dramatically change how researchers think about tissue development, stem cells and cancer.

15 Feb 2010

NRF and MOE fund support for SCELSE microbial biofilm research centre

The National Research Foundation (NRF) and the Ministry of Education (MOE) announced today the funding support for a Research Centre of Excellence (RCE) called the Singapore Centre on Environmental Life Sciences Engineering (SCELSE) to be set up at the Nanyang Technological University (NTU).

15 Feb 2010

CEO Roundtable on Cancer salutes Duke Blue Devils basketball team coach on 1000th game

The CEO Roundtable on Cancer salutes Mike Krzyzewski, who on Saturday, February 13th will celebrate his 1000th game leading the Duke Blue Devils men’s basketball team. Tomorrow afternoon’s game at 1 pm against the University of Maryland will mark an amazing achievement only seven other coaches in the history of the game have done at a single school. Beginning in 1980, Coach K’s career at Duke has been nothing short of incredible, including leading the school to 294 wins from 2000-09 – the most in the history of the game by any school in any decade.

15 Feb 2010

Structure of 'DNA repair engine' that reverses beneficial effects of chemotherapy deciphered

Cancer Research UK scientists have deciphered the first structure of 'a DNA repair engine' that reverses the beneficial effects of chemotherapy, according to research published in Nature Structural and Molecular Biology* today.

15 Feb 2010

Research findings may open door to new therapeutic strategies for serious health problems

Drugs that target the way cells convert nutrients into energy could offer new approaches to treating a range of conditions including heart attack and stroke. Using a new way to screen for potential drugs, a team led by Massachusetts General Hospital (MGH) researchers has identified several FDA-approved agents, including an over-the-counter anti-nausea drug, that can shift cellular energy metabolism processes in animals.

15 Feb 2010

Potential cancer-killing compounds synthesized

Yale University scientists have streamlined the process for synthesizing a family of compounds with the potential to kill cancer and other diseased cells, and have found that they represent a unique category of anti-cancer agents. Their discovery appears in this week's online edition of the Journal of the American Chemical Society.

15 Feb 2010

Bioniche Life Sciences meets obligations under licensing agreement with Endo Pharmaceuticals

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced that it has met the obligations associated with two milestones under its licensing agreement with Endo Pharmaceuticals for exclusive rights to develop and market Bioniche's proprietary product for non-muscle-invasive bladder cancer in North America.

15 Feb 2010

National MS Society launches We Keep Moving campaign to capture stories of people living with MS

For every person living with and affected by MS there is a unique story about how they move forward with their lives. That is why the National Multiple Sclerosis Society is launching We Keep Moving, a viewer-driven reality campaign that will capture these stories and perspectives through online videos that chronicle how people across the country keep moving forward while living with MS

15 Feb 2010

Cancer News and Research

Latest Cancer News and Research

Minority patients more likely to have surgeries at centres handling low numbers of similar procedures

Over 96% of SIDS cases due to known risk factors

US Oncology honored as inaugural inductee to Texas Governor's Business Hall of Fame

CNRS-Institut researchers identify 'virulence factor' that inhibits host immune response

NorTech announces winners of annual Innovation Awards program

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Public health researchers at UNC to lead multi-state initiative to prevent cervical cancer

Annual Income Tax Check-Off for Breast and Cervical Research campaign launched

Researchers identify potential therapeutic targets for treatment of neuroblastoma

ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center

LCA announces new internet link with renowned lung cancer research center in Zhuhai, China

New conference to discuss issues surrounding breast cancer to take place at UWE

Stem cells intentionally cut and then repair their own DNA to develop new tissues

NRF and MOE fund support for SCELSE microbial biofilm research centre

CEO Roundtable on Cancer salutes Duke Blue Devils basketball team coach on 1000th game

Structure of 'DNA repair engine' that reverses beneficial effects of chemotherapy deciphered

Research findings may open door to new therapeutic strategies for serious health problems

Potential cancer-killing compounds synthesized

Bioniche Life Sciences meets obligations under licensing agreement with Endo Pharmaceuticals

National MS Society launches We Keep Moving campaign to capture stories of people living with MS

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in